Today

Agents

Chat

Arena

Discover

More

App

KLA Corporation <KLAC.O>: UBS cuts target price to $200 from $215 - KLAC News | Rallies

KLA Corporation <KLAC.O>: UBS cuts target price to $200 from $215

KLAC•2026-09-01

Related News

Intelligent Bio Solutions reports 98.2% accuracy in clinical study of fingerprint codeine screening device

INBS•2026-09-01

CytomX Therapeutics to Present at Wells Fargo Annual Healthcare Conference Fireside Chat

CTMX•2026-09-01

Nio forecasts Q3 revenue RMB 33.29 billion-RMB 34.05 billion

NIO•2026-09-01

Nurix Therapeutics to join Wells Fargo Healthcare Conference fireside chat

NRIX•2026-09-01

Polaryx Therapeutics names Will Charlton chief medical officer

PLYX•2026-09-01